|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Renal Transplantation |


,




,


,

* Department of Pediatrics,
Recanati/Miller Transplantation Institute,
Departments of Surgery, Gene and Cell Medicine, Center for Immunobiology, || Department of Medicine, and ¶ Department of Pathology, The Mount Sinai Medical Center, New York, New York;
Department of Pediatrics, Children's Hospital of Pittsburgh of University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania; ** Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas; 
Department of Surgery, Yale University School of Medicine, New Haven, Connecticut; 
Department of Medicine and Transplantation, Ospedali Riuniti di Bergamo, Bergamo, Italy; and 
"Mario Negri" Institute for Pharmacological Research, Bergamo, Italy
Correspondence: Dr. Jeffrey M. Saland, Department of Pediatrics, Box 1664, The Mount Sinai Medical Center, One Gustave L. Levy Place, New York, NY 10029. Phone: 212-241-6187; Fax: 212-426-1972; E-mail: Jeff.Saland{at}MSSM.EDU
Background and objectives: A male infant with a family history of thrombotic microangiopathy developed atypical hemolytic uremic syndrome (aHUS).
Design, setting, participants, & measurements: Case report.
Results: Genetic analysis demonstrated a heterozygous mutation (S1191L) of CFH, the gene coding complement factor H (CFH). The child suffered many episodes of HUS, each treated with plasma exchange. In time, despite initiation of a prophylactic regimen of plasma exchange, his renal function declined significantly. At the age of 4 yr he received a (split liver) combined liver-kidney transplant (LKT) with preoperative plasma exchange and enoxaparin anticoagulation. Initial function of both grafts was excellent and is maintained for nearly 2 yr.
Conclusions: This report adds to the small but growing number of individuals in whom LKT has provided a favorable outcome for aHUS associated with CFH mutation, expands the technique of using a split liver graft, and describes the unique histologic features of subclinical liver disease in HUS.
This article has been cited by other articles:
![]() |
J.-P. Grunfeld Lessons from Rare Renal and Adrenal Diseases Clin. J. Am. Soc. Nephrol., May 1, 2009; 4(5): 870 - 872. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |